ASN Report 2018

T he Paris division regulates radiation protection and the transport of radioactive substances in the 8 départements of the Île‑de‑France region. The Orléans division regulates nuclear safety in the basic nuclear installations of this region. Île-de-France region ASN carried out 202 inspections in the Île-de-France region in 2018, of which 42 were in the field of nuclear safety, 151 in small-scale nuclear activities and 9 in the transport of radioactive substances. Four Safety-related Significant Events (ESS) notified in Île-de- France and concerning BNIs were rated level 1 on the INES scale. In the small-scale nuclear activities, 3 Significant Events relating to Radiation protection (ESR) were rated level 1 on the INES scale, while 10 events concerning radiotherapy patients were rated level 1 on the ASN-SFRO scale. ASN drew up two violation in the exercise of its oversight duties. Saclay site CEA Saclay Centre The Saclay centre, covering an area of 223 hectares, is located about 20 km south-west of Paris, in the Essonne département . Some 6,000 people work there. Since 2005, this centre has been primarily devoted to physical sciences, fundamental research and applied research. The applications concern physics, metallurgy, electronics, biology, climatology, simulation, chemistry and the environment. Themain aimof applied nuclear research is to optimise the operation of the French NPPs and their safety. Eight BNIs are located in this centre. It also houses an office of the French national institute for nuclear science and technology (training institute) and REGIONAL OVERVIEWOF NUCLEAR SAFETY AND RADIATION PROTECTION THE INSTALLATIONS AND ACTIVITIES TO REGULATE COMPRISE: ཛྷ ཛྷ Basic Nuclear Installations regulated by the Orléans division: t ݸݸ he CEA Saclay centre, including in particular the experimental reactors Osiris and Orphée; t ݸݸ he UPRA (Artificial Radionuclide Production Plant) operated by CIS bio international in Saclay; t ݸݸ he CEA Fontenay‑aux‑Roses centre; ཛྷ ཛྷ small-scale nuclear activities in the medical sector regulated by the Paris division: ݸݸ 26 external-beam radiotherapy departments; ݸݸ 14 brachytherapy departments;  ݸݸ 40 in-vivo nuclear medicine departments and 16 in-vitro (medical biology) nuclear medicine departments; ݸݸ 153 centres performing fluoroscopy-guided interventional procedures; ݸݸ more than 200 centres in possession of at least one Computed Tomography (CT) scanner; ݸݸ about 850 medical radiology centres; ݸݸ about 8,000 dental radiology devices; ཛྷ ཛྷ small-scale nuclear activities in the veterinary, industrial and research sectorsunder the oversight of the Paris division: ݸݸ about 650 users of veterinary radiology devices; ݸݸ 9 industrial radiography companies using gamma radiography devices; ݸݸ about 160 licenses concerning research activities involving unsealed radioactive sources; ཛྷ ཛྷ activities linked to the transport of radioactive substances ; ཛྷ ཛྷ organisations approved by ASN: 1 ݸݸ 2 organisations approved for radiation protection controls. see p. 200 see p. 230 see p. 256 56  ASN report on the state of nuclear safety and radiation protection in France in 2018